Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
Joanna Groom, … , Charles R. Mackay, Fabienne Mackay
Joanna Groom, … , Charles R. Mackay, Fabienne Mackay
Published January 1, 2002
Citation Information: J Clin Invest. 2002;109(1):59-68. https://doi.org/10.1172/JCI14121.
View: Text | PDF
Article Article has an altmetric score of 9

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome

  • Text
  • PDF
Abstract

BAFF (BLyS, TALL-1, THANK, zTNF4) is a member of the TNF superfamily that specifically regulates B lymphocyte proliferation and survival. Mice transgenic (Tg) for BAFF develop an autoimmune condition similar to systemic lupus erythematosus. We now demonstrate that BAFF Tg mice, as they age, develop a secondary pathology reminiscent of Sjögren’s syndrome (SS), which is manifested by severe sialadenitis, decreased saliva production, and destruction of submaxillary glands. In humans, SS also correlates with elevated levels of circulating BAFF, as well as a dramatic upregulation of BAFF expression in inflamed salivary glands. A likely explanation for disease in BAFF Tg mice is excessive survival signals to autoreactive B cells, possibly as they pass through a critical tolerance checkpoint while maturing in the spleen. The marginal zone (MZ) B cell compartment, one of the enlarged B cell subsets in the spleen of BAFF Tg mice, is a potential reservoir of autoreactive B cells. Interestingly, B cells with an MZ-like phenotype infiltrate the salivary glands of BAFF Tg mice, suggesting that cells of this compartment potentially participate in tissue damage in SS and possibly other autoimmune diseases. We conclude that altered B cell differentiation and tolerance induced by excess BAFF may be central to SS pathogenesis.

Authors

Joanna Groom, Susan L. Kalled, Anne H. Cutler, Carl Olson, Stephen A. Woodcock, Pascal Schneider, Jurg Tschopp, Teresa G. Cachero, Marcel Batten, Julie Wheway, Davide Mauri, Dana Cavill, Tom P. Gordon, Charles R. Mackay, Fabienne Mackay

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Total
Citations: 1 6 8 12 16 11 5 13 16 10 15 12 20 11 21 14 24 12 20 14 8 7 8 4 288
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (288)

Title and authors Publication Year
Carboxyamidotriazole Regulates the Function of Salivary Gland Epithelial Cells and B Cells to Alleviate Experimental Sjögren′s Disease in Mice
Zhang X, Liu J, Yang M, Li J, Zhu L
International Journal of Medical Sciences 2025
Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's syndrome
Renaud Felten, Anne-Perrine Foray, Pascal Schneider, Cindy Marquet, Coralie Pecquet, Fanny Monneaux, Hélène Dumortier, Jean Sibilia, Fabrice Valette, Lucienne Chatenoud, Jacques-Eric Gottenberg
RMD open 2024
B cell focused transient immune suppression protocol for efficient AAV readministration to the liver
Rana J, Herzog RW, Muñoz-Melero M, Yamada K, Kumar SR, Lam AK, Markusic DM, Duan D, Terhorst C, Byrne BJ, Corti M, Biswas M
2024
B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren’s Disease: A Pilot Monocentric Exploratory Study
Bruno D, Tolusso B, Lugli G, Di Mario C, Petricca L, Perniola S, Bui L, Benvenuto R, Ferraccioli G, Alivernini S, Gremese E
International journal of molecular sciences 2024
Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren's syndrome in mice by promoting TEC kinase degradation.
Yang YQ, Liu YJ, Qiao WX, Jin W, Zhu SW, Yan YX, Luo Q, Xu Q
Acta Pharmacologica Sinica 2024
Splenic marginal zone B cells restrict Mycobacterium tuberculosis infection by shaping the cytokine pattern and cell-mediated immunity.
Tsai CY, Oo M, Peh JH, Yeo BCM, Aptekmann A, Lee B, Liu JJJ, Tsao WS, Dick T, Fink K, Gengenbacher M
Cell Reports 2024
The role of cytokines from salivary gland epithelial cells in the immunopathology of Sjögren’s syndrome
Dong Y, Wang T, Wu H
Frontiers in Immunology 2024
An Overview of the Dry Eye Disease in Sjögren’s Syndrome Using Our Current Molecular Understanding
Wu KY, Kulbay M, Tanasescu C, Jiao B, Nguyen BH, Tran SD
International journal of molecular sciences 2023
Association of Serum BAFF Levels with Cardiovascular Events in ST-Segment Elevation Myocardial Infarction
Wang Z, Wang Y, Cui Y, Chen Z, Yi L, Zhu Z, Ni J, Du R, Wang X, Zhu J, Ding F, Quan W, Zhang R, Hu J, Yan X
Journal of Clinical Medicine 2023
Mitochondria as disease-relevant organelles in rheumatoid arthritis.
Weyand CM, Wu B, Huang T, Hu Z, Goronzy JJ
Clinical & Experimental Immunology 2023
Targeting alarmin release reverses Sjogren's syndrome phenotype by revitalizing Ca2+ signalling
Sun Y, Nascimento Da Conceicao V, Chauhan A, Sukumaran P, Chauhan P, Ambrus JL, Vissink A, Kroese FG, Muniswamy M, Mishra BB, Singh BB
Clinical and Translational Medicine 2023
The characteristics of chest HRCT and pulmonary function tests in lung‐onset primary sjogren's syndrome
Dong X, Gao Y, Li M, Wang D, Li J, Zhang Y
Immunity, Inflammation and Disease 2023
Associations between TNFSF13B polymorphisms and primary Sjögren's syndrome susceptibility in primary Sjögren's syndrome patients: A meta‐analysis
Zheng A, Hu N, Xu J, Yuan Y, Zhang S, Chen W, Bai Y, Sun H
Immunity, Inflammation and Disease 2023
The role of microRNAs involved in the disorder of blood–brain barrier in the pathogenesis of multiple sclerosis
Emami Nejad A, Mostafavi Zadeh SM, Nickho H, Sadoogh Abbasian A, Forouzan A, Ahmadlou M, Nedaeinia R, Shaverdi S, Manian M
Frontiers in immunology 2023
Research hotspots and emerging trends in the treatment of Sjogren's syndrome: A bibliometric analysis from 1900 to 2022
Song W, Wang H, Wang X
Heliyon 2023
Stromal Notch ligands foster lymphopenia-driven functional plasticity and homeostatic proliferation of naïve B cells
Daniela Gómez Atria, Brian T. Gaudette, Jennifer Londregan, Samantha Kelly, Eric Perkey, Anneka Allman, Bhaskar Srivastava, Ute Koch, Freddy Radtke, Burkhard Ludewig, Christian W. Siebel, Russell J.H. Ryan, Tanner F. Robertson, Janis K. Burkhardt, Warren S. Pear, David Allman, Ivan Maillard
Journal of Clinical Investigation 2022
The Immunogenetics of Dermatologic Diseases
N Rezaei, F Rajabi
2022
Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome
J Zhou, X Zhang, Q Yu
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022
Abnormal Epigenetic Regulations in the Immunocytes of Sjögren’s Syndrome Patients and Therapeutic Potentials
Li P, Han M, Zhao X, Ren G, Mei S, Zhong C
Cells 2022
Decreased BAFF Receptor Expression and Unaltered B Cell Receptor Signaling in Circulating B Cells from Primary Sjögren's Syndrome Patients at Diagnosis.
Neys SFH, Verstappen GM, Bootsma H, Kroese FGM, Hendriks RW, Corneth OBJ
International journal of molecular sciences 2022
Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview
Chu KY, Yu HS, Yu S
Journal of Clinical Medicine 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Inoue Y, Inui N, Karayama M, Asada K, Matsuura S, Ikeda M, Uto T, Fujii M, Hashimoto D, Matsui T, Matsuda H, Inami N, Toyoshima M, Kaida Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T
Journal of Cancer Research and Clinical Oncology 2022
Loss of T cell tolerance in the skin following immunopathology is linked to failed restoration of the dermal niche by recruited macrophages.
West HC, Davies J, Henderson S, Adegun OK, Ward S, Ferrer IR, Tye CA, Vallejo AF, Jardine L, Collin M, Polak ME, Bennett CL
Cell Reports 2022
Kinetics of free and ligand-bound atacicept in human serum
Eslami M, Willen D, Papasouliotis O, Schuepbach-Mallpell S, Willen L, Donzé O, Yalkinoglu Ö, Schneider P
Frontiers in immunology 2022
Humoral response in Leishmaniasis
Conde L, Maciel G, de Assis GM, Freire-de-Lima L, Nico D, Vale A, Freire-de-Lima CG, Morrot A
Frontiers in Cellular and Infection Microbiology 2022
Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
Marín-Rosales M, Palafox-Sánchez CA, Franco-Topete RA, Carrillo-Ballesteros FJ, Cruz A, Salazar-Camarena DC, Muñoz-Valle JF, Ramos-Solano F
Journal of Clinical Medicine 2022
The effects of B‐cell–activating factor on the population size, maturation and function of murine natural killer cells
Quah PS, Sutton V, Whitlock E, Figgett WA, Andrews DM, Fairfax KA, Mackay F
Immunology and Cell Biology 2022
TLR7 Signaling Drives the Development of Sjögren’s Syndrome
Y Wang, A Roussel-Queval, L Chasson, NH Kazazian, L Marcadet, A Nezos, MH Sieweke, C Mavragani, L Alexopoulou
Frontiers in immunology 2021
Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
G Lauriero, L Abbad, M Vacca, G Celano, JM Chemouny, M Calasso, L Berthelot, L Gesualdo, MD Angelis, RC Monteiro
Frontiers in immunology 2021
B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease
EM Matson, ML Abyazi, KA Bell, KM Hayes, PJ Maglione
Frontiers in immunology 2021
Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren’s Syndrome
T Shimizu, H Nakamura, A Kawakami
International journal of molecular sciences 2021
Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren’s Syndrome: Clues for a Personalized Medicine
L Quartuccio, GD Marchi, S Longhino, V Manfrè, MT Rizzo, S Gandolfo, A Tommasini, SD Vita, R Fox
Frontiers in immunology 2021
Autoimmune B Cell Repertoire in a Mouse Model of Sjögren’s Syndrome
MS Moya, R Gutiérrez-Cózar, J Puñet-Ortiz, ML de la Concepción, J Blanco, J Carrillo, P Engel
Frontiers in immunology 2021
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
A Romano, P Storti, V Marchica, G Scandura, L Notarfranchi, L Craviotto, FD Raimondo, N Giuliani
Frontiers in Oncology 2021
Genetics and epigenetics in primary Sjögren’s syndrome
J Imgenberg-Kreuz, A Rasmussen, K Sivils, G Nordmark
Rheumatology 2021
Advances in Pathogenesis of Sjögren’s Syndrome
Y Tian, H Yang, N Liu, Y Li, J Chen, Y Yang
Journal of Immunology Research 2021
Rituximab Therapy for Primary Sjögren’s Syndrome
YH Chen, XY Wang, X Jin, Z Yang, J Xu
Frontiers in pharmacology 2021
Effects of Dietary Brown Rice on the Growth Performance, Systemic Oxidative Status, and Splenic Inflammatory Responses of Broiler Chickens under Chronic Heat Stress
F Nanto-Hara, H Ohtsu, M Yamazaki, T Hirakawa, K Sato, H Murakami
The Journal of Poultry Science 2021
Thymic Epithelial Cell Alterations and Defective Thymopoiesis Lead to Central and Peripheral Tolerance Perturbation in MHCII Deficiency
F Ferrua, I Bortolomai, E Fontana, DD Silvestre, R Rigoni, GE Marcovecchio, E Draghici, F Brambilla, MC Castiello, G Delfanti, D Moshous, C Picard, T Taghon, V Bordon, AS Schulz, C Schuetz, S Giliani, A Soresina, AR Gennery, S Signa, BJ Saldaña, OM Delmonte, LD Notarangelo, CM Roifman, PL Poliani, P Uva, PL Mauri, A Villa, M Bosticardo
Frontiers in immunology 2021
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long‐standing nodding syndrome: A case‐control study
R Ogwang, D Muhanguzi, K Mwikali, R Anguzu, J Kubofcik, TB Nutman, M Taylor, CR Newton, A Vincent, AL Conroy, K Marsh, R Idro
Epilepsia Open 2021
Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease.
Kumric M, Zivkovic PM, Ticinovic Kurir T, Vrdoljak J, Vilovic M, Martinovic D, Bratanic A, Lizatovic IK, Bozic J
2021
New developments in Sjogren's syndrome.
Thalayasingam N, Baldwin K, Judd C, Ng WF
Rheumatology (Oxford, England) 2021
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Liu W, Stachura P, Xu HC, Váraljai R, Shinde P, Ganesh NU, Mack M, Van Lierop A, Huang A, Sundaram B, Lang KS, Picard D, Fischer U, Remke M, Homey B, Roesch A, Häussinger D, Lang PA, Borkhardt A, Pandyra AA
Cancer research 2021
Sex differences in lymphoid follicles in COPD airways
A Tam, N Tanabe, A Churg, JL Wright, JC Hogg, DD Sin
Respiratory Research 2020
Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren’s syndrome
K Yoshimoto, K Suzuki, E Takei, Y Ikeda, T Takeuchi
Arthritis Research & Therapy 2020
Recent Advances in Mouse Models of Sjögren's Syndrome
Y Gao, Y Chen, Z Zhang, X Yu, J Zheng
Frontiers in immunology 2020
Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation
C Rizzo, G Grasso, GM Castaniti, F Ciccia, G Guggino
Human vaccines 2020
High-throughput investigation of molecular and cellular biomarkers in NMOSD
SS Yandamuri, R Jiang, A Sharma, E Cotzomi, C Zografou, AK Ma, JS Alvey, LJ Cook, TJ Smith, MR Yeaman, KC O'Connor
Neurology: Neuroimmunology & Neuroinflammation 2020
Contributions of Major Cell Populations to Sjögren’s Syndrome
R Witas, S Gupta, CQ Nguyen
Journal of Clinical Medicine 2020
Pathogenetic Mechanisms Implicated in Sjögren’s Syndrome Lymphomagenesis: A Review of the Literature
IE Stergiou, A Poulaki, M Voulgarelis
Journal of Clinical Medicine 2020
Mouse Models of Sjögren’s Syndrome with Ocular Surface Disease
S Masli, DA Dartt
International journal of molecular sciences 2020
Studying Sjögren's syndrome in mice: What is the best available model?
G Abughanam, OM Mari, SD Tran
Journal of Oral Biology and Craniofacial Research 2020
Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome
A Srivastava, HP Makarenkova
International journal of molecular sciences 2020
Investigative biological therapies for primary Sjögren’s syndrome
He SH, Xuan YY, Liang X, Guo KJ, Wang Y, Fu XN, Li TF
Archives of Medical Science : AMS 2020
Serum markers of B-cell activation in pregnancy during late gestation, delivery, and the postpartum period
J Lima, G Cambridge, A Vilas-Boas, C Martins, LM Borrego, M Leandro
American Journal of Reproductive Immunology 2019
Current Clinical Trials in Pemphigus and Pemphigoid
K Izumi, K Bieber, RJ Ludwig
Frontiers in immunology 2019
BAFF inhibition in SLE—Is tolerance restored?
SW Jackson, A Davidson
Immunological Reviews 2019
Physiology, Pathology and Regeneration of Salivary Glands
Porcheri, Mitsiadis
Cells 2019
Lupus serum IgG induces microglia activation through Fc fragment dependent way and modulated by B-cell activating factor
C Yang, X Hou, Q Feng, Y Li, X Wang, L Qin, P Yang
Journal of Translational Medicine 2019
Tertiary Lymphoid Structures: Autoimmunity Goes Local
E Pipi, S Nayar, DH Gardner, S Colafrancesco, C Smith, F Barone
Frontiers in immunology 2018
Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21 −/low B Cells From Patients With Sjögren's Syndrome
S Glauzy, M Boccitto, JM Bannock, FR Delmotte, D Saadoun, P Cacoub, JA Ice, KL Sivils, JA James, SL Wolin, E Meffre
Arthritis & Rheumatology 2018
Tailoring Immune Responses toward Autoimmunity: Transcriptional Regulators That Drive the Creation and Collusion of Autoreactive Lymphocytes
KL Good-Jacobson, JR Groom
Frontiers in immunology 2018
Acquisition of N-Glycosylation Sites in Immunoglobulin Heavy Chain Genes During Local Expansion in Parotid Salivary Glands of Primary Sjögren Patients
A Visser, ME Doorenspleet, N de Vries, FK Spijkervet, A Vissink, RJ Bende, H Bootsma, FG Kroese, NA Bos
Frontiers in immunology 2018
Immunophenotypes and clinical features of lymphocytes in the labial gland of primary Sjogren's syndrome patients
W Sun, N Zhang, Y Zhang, Z Shao, L Gong, W Wei
Journal of Clinical Laboratory Analysis 2018
B-cell activity markers are associated with different disease activity domains in primary Sjögren’s syndrome
K James, C Chipeta, A Parker, S Harding, SJ Cockell, CS Gillespie, J Hallinan, F Barone, SJ Bowman, WF Ng, BA Fisher
Rheumatology 2018
BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus
W Shin, HT Lee, H Lim, SH Lee, JY Son, JU Lee, KY Yoo, SE Ryu, J Rhie, JY Lee, YS Heo
Nature Communications 2018
Current Insights in Microbiome Shifts in Sjogren’s Syndrome and Possible Therapeutic Interventions
C Tsigalou, E Stavropoulou, E Bezirtzoglou
Frontiers in immunology 2018
Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells
SW Du, HM Jacobs, T Arkatkar, DJ Rawlings, SW Jackson
Journal of immunology (Baltimore, Md. : 1950) 2018
Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren’s Syndrome
J Kiripolsky, JM Kramer
Journal of Immunology Research 2018
Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren’s syndrome
P Olsson, K Skogstrand, A Nilsson, C Turesson, LT Jacobsson, E Theander, G Houen, T Mandl
Rheumatology International 2018
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome
S Nayar, J Campos, CG Smith, V Iannizzotto, DH Gardner, S Colafrancesco, E Pipi, F Kollert, KJ Hunter, C Brewer, CD Buckley, SJ Bowman, R Priori, G Valesini, M Juarez, WA Fahy, BA Fisher, A Payne, RA Allen, F Barone
Annals of the rheumatic diseases 2018
B cells in the pathogenesis of primary Sjögren syndrome
G Nocturne, X Mariette
Nature Reviews Rheumatology 2018
H1N1 vaccination in Sjögren’s syndrome triggers polyclonal B cell activation and promotes autoantibody production
S Brauner, L Folkersen, M Kvarnström, S Meisgen, S Petersen, M Franzén-Malmros, J Mofors, KA Brokstad, L Klareskog, R Jonsson, LS Westerberg, C Trollmo, V Malmström, A Ambrosi, VK Kuchroo, G Nordmark, M Wahren-Herlenius
Annals of the rheumatic diseases 2017
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells
P Haselmayer, M Vigolo, J Nys, P Schneider, H Hess
European Journal of Immunology 2017
Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
Y Fu, L Wang, C Xie, K Zou, L Tu, W Yan, X Hou
Scientific Reports 2017
New insights into the pathogenesis of IgA nephropathy
SC Yeo, CK Cheung, J Barratt
Pediatric Nephrology 2017
CD19 regulates ADAM28-mediated Notch2 cleavage to control the differentiation of marginal zone precursors to MZ B cells
Y Zhang, G Zhu, H Xiao, X Liu, G Han, G Chen, C Hou, B Shen, Y Li, N Ma, R Wang
Journal of Cellular and Molecular Medicine 2017
B cell activating factor (BAFF) and BAFF receptors: fakes and facts: BAFF and BAFF receptors
G Ferraccioli, E Gremese
Clinical & Experimental Immunology 2017
Env-Specific Antibodies in Chronic Infection versus in Vaccination
M Soldemo, GB Hedestam
Frontiers in immunology 2017
The Pathophysiology of Dry Eye Disease
SC Pflugfelder, CS de Paiva
Ophthalmology 2017
The Role of BAFF System Molecules in Host Response to Pathogens
J Sakai, M Akkoyunlu
Clinical microbiology reviews 2017
Predictable biomarkers of developing lymphoma in patients with Sjögren syndrome: a nationwide population-based cohort study
YH Chiu, CH Chung, KT Lin, CS Lin, JH Chen, HC Chen, RY Huang, CT Wu, FC Liu, WC Chien
Oncotarget 2017
Sjogren's syndrome: Review of the aetiology, Pathophysiology a Potential therapeutic interventions
JJ Nair, TP Singh
Journal of Clinical and Experimental Dentistry 2017
Sex differential association of dermatomyositis with Sjögren syndrome
CC Tseng, SJ Chang, WC Tsai, TT Ou, CC Wu, WY Sung, MC Hsieh, JH Yen
CMAJ : Canadian Medical Association Journal 2017
B Cells Are Indispensable for a Novel Mouse Model of Primary Sjögren’s Syndrome
J Zheng, Q Huang, R Huang, F Deng, X Yue, J Yin, W Zhao, Y Chen, L Wen, J Zhou, R Huang, G Riemekasten, Z Liu, F Petersen, X Yu
Frontiers in immunology 2017
B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection
G Borhis, M Trovato, N Chaoul, HM Ibrahim, Y Richard
Frontiers in immunology 2017
Innate immunity in Sjögren's syndrome
J Kiripolsky, LG McCabe, JM Kramer
Clinical Immunology 2017
What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?
AB Peck, CQ Nguyen
Clinical Immunology 2017
Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease
PI Lobo
Frontiers in immunology 2016
Aquaporin gene therapy corrects Sjögren’s syndrome phenotype in mice
Z Lai, H Yin, J Cabrera-Pérez, MC Guimaro, S Afione, DG Michael, P Glenton, A Patel, WD Swaim, C Zheng, CQ Nguyen, F Nyberg, JA Chiorini
Proceedings of the National Academy of Sciences 2016
B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease
P Zhang, X Liu, A Guo, J Xiong, Y Fu, K Zou
Digestive Diseases and Sciences 2016
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases
M Uzzan, JF Colombel, A Cerutti, X Treton, S Mehandru
Digestive Diseases and Sciences 2016
Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction
A Sharma, J Kiripolsky, E Klimatcheva, A Howell, F Fereidouni, R Levenson, TL Rothstein, JM Kramer
Clinical Immunology 2016
Recent advances in primary Sjogren's syndrome
N Holdgate, EW St.Clair
F1000Research 2016
Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases
JD Lin, SF Yang, YH Wang, WF Fang, YC Lin, YF Lin, KT Tang, MY Wu, CW Cheng, H Ariga
PloS one 2016
Rituximab Effectiveness and Safety for Treating Primary Sjögren’s Syndrome (pSS): Systematic Review and Meta-Analysis
FB Souza, GJ Porfírio, BN Andriolo, JV de Albuquerque, VF Trevisani, S Appel
PloS one 2016
Multiple Roles for B-Lymphocytes in Sjogren’s Syndrome
J Ambrus, L Suresh, A Peck
Journal of Clinical Medicine 2016
CD40 SIGNALING IN GRAVES’ DISEASE IS MEDIATED THROUGH CANONICAL AND NON-CANONICAL THYROIDAL NF-κB ACTIVATION
HJ Lee, A Lombardi, M Stefan, C Li, WB Inabnet, RP Owen, E Concepcion, Y Tomer
Endocrinology 2016
The osteopontin transgenic mouse is a new model for Sjögren's syndrome
S Husain-Krautter, JM Kramer, W Li, B Guo, TL Rothstein
Clinical Immunology 2015
Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome
NS Kolhatkar, A Brahmandam, CD Thouvenel, S Becker-Herman, HM Jacobs, MA Schwartz, EJ Allenspach, S Khim, AK Panigrahi, ET Prak, AJ Thrasher, LD Notarangelo, F Candotti, TR Torgerson, I Sanz, DJ Rawlings
Journal of Experimental Medicine 2015
Analysis of IgM antibody production and repertoire in a mouse model of Sjo grens syndrome
JM Kramer, NE Holodick, TC Vizconde, I Raman, M Yan, QZ Li, DP Gaile, TL Rothstein
Journal of leukocyte biology 2015
The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review
Y Sun, W Zhang, B Li, Z Zou, C Selmi, ME Gershwin
Clinical Reviews in Allergy & Immunology 2015
Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents
P Lenert, A Lenert
Drug design, development and therapy 2015
B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome
MC Castiello, S Scaramuzza, F Pala, F Ferrua, P Uva, I Brigida, L Sereni, M der Burg, G Ottaviano, MH Albert, MG Roncarolo, L Naldini, A Aiuti, A Villa, M Bosticardo
Journal of Allergy and Clinical Immunology 2015
Association of BAFF −871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients
MW Ayad, AA Elbanna, DA Elneily, AS Sakr
Molecular diagnosis & therapy 2015
Factors Regulating Immunoglobulin Production by Normal and Disease-Associated Plasma Cells
D Jackson, S Elsawa
Biomolecules 2015
The clinical relevance of animal models in Sjögren’s syndrome: the interferon signature from mouse to man
NI Maria, P Vogelsang, MA Versnel
Arthritis Research & Therapy 2015
B-cell survival factors in autoimmune rheumatic disorders
SA Morais, A Vilas-Boas, DA Isenberg
Therapeutic Advances in Musculoskeletal Diseases 2015
CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity
Y Sun, L Sun, Y Richard
PloS one 2015
The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren’s syndrome – a preliminary study
M Maślińska, E Kontny, B Kwiatkowska
Reumatologia/Rheumatology 2015
Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses
M Cuenca, X Romero, J Sintes, C Terhorst, P Engel
Journal of immunology (Baltimore, Md. : 1950) 2015
The Expression of BAFF Is Controlled by IRF Transcription Factors
M Sjostrand, A Johansson, L Aqrawi, T Olsson, M Wahren-Herlenius, A Espinosa
Journal of immunology (Baltimore, Md. : 1950) 2015
Mouse models of primary Sjögren’s syndrome
Park YS, Gauna AE, Cha S
Current pharmaceutical design 2015
Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications
Lili Magyari, Dalma Varszegi, Erzsebet Kovesdi, Patricia Sarlos, Bernadett Farago, Andras Javorhazy, Katalin Sumegi, Zsolt Banfai, Bela Melegh
World Journal of Orthopedics 2014
Matriptase Deletion Initiates a Sjögren's Syndrome-Like Disease in Mice
H Yin, P Kosa, X Liu, WD Swaim, Z Lai, J Cabrera-Perez, GD Pasquale, IS Ambudkar, TH Bugge, JA Chiorini
PloS one 2014
Novel treatments for immune thrombocytopenia
A Shih, I Nazi, JG Kelton, DM Arnold
La Presse Médicale 2014
Acquired Hemophilia A: A Frequently Overlooked Autoimmune Hemorrhagic Disorder
Y Sakurai, T Takeda
Journal of Immunology Research 2014
Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis
G Feng, X Xue, M Gao, X Wang, Z Shu, N Mu, Y Gao, Z Wang, Q Hao, W Li, M Li, C Zhang, W Zhang, Y Zhang
BioMed Research International 2014
BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells
D Liang, Q Zeng, Z Xu, H Zhang, L Gui, C Xu, S Chen, S Zhang, S Huang, L Chen
Biochemical Pharmacology 2014
Reduced BAFF-R and Increased TACI Expression in Common Variable Immunodeficiency
RR Barbosa, SL Silva, SP Silva, AC Melo, MC Pereira-Santos, JT Barata, L Hammarström, M Cascalho, AE Sousa
Journal of Clinical Immunology 2014
Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis: MTX and Etanercept Differentially Affect B Cells in JIA
S Glaesener, TD Quách, N Onken, F Weller-Heinemann, F Dressler, HI Huppertz, A Thon, A Meyer-Bahlburg
Arthritis & Rheumatology 2014
Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus
D Malheiros, RA Panepucci, AM Roselino, AG Araújo, MA Zago, ML Petzl-Erler
Immunology 2014
Autoimmunity in the Pathogenesis and Treatment of Keratoconjunctivitis Sicca
KC Liu, K Huynh, J Grubbs, RM Davis
Current Allergy and Asthma Reports 2014
Elevation of Serum B-Cell Activating Factor Levels During Visceral Leishmaniasis
Y Goto, S Omachi, C Sanjoba, Y Matsumoto
The American journal of tropical medicine and hygiene 2014
The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms
A Donate, A Voigt, CQ Nguyen
Expert Review of Clinical Immunology 2014
Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation
D Saadoun, B Terrier, J Bannock, T Vazquez, C Massad, I Kang, F Joly, M Rosenzwajg, D Sene, P Benech, L Musset, D Klatzmann, E Meffre, P Cacoub
Arthritis & Rheumatism 2013
BMP6 is associated with exocrine gland dysfunction in Sjögren's syndrome patients and mice
H Yin, J Cabrera-Perez, Z Lai, D Michael, M Weller, W Swaim, X Liu, MA Catalán, EM Rocha, N Ismail, S Afione, N Rana, GD Pasquale, I Alevizos, I Ambudkar, GG Illei, JA Chiorini
Arthritis & Rheumatism 2013
CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis
JM Kramer, E Klimatcheva, TL Rothstein
Journal of leukocyte biology 2013
Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans
MC Castiello, M Bosticardo, F Pala, M Catucci, N Chamberlain, MC van Zelm, GJ Driessen, M Pac, E Bernatowska, S Scaramuzza, A Aiuti, AV Sauer, E Traggiai, E Meffre, A Villa, M der Burg
Journal of Autoimmunity 2013
Empfehlungen zum Einsatz von Belimumab beim systemischen Lupus erythematodes
R Fischer-Betz, M Schneider
Zeitschrift für Rheumatologie 2013
B-cell activating factor (BAFF) is elevated in Chronic Granulomatous Disease
K Matharu, KA Zarember, BE Marciano, DB Kuhns, C Spalding, M Garofalo, T Dimaggio, T Estwick, CY Huang, D Fink, DL Priel, TA Fleisher, SM Holland, HL Malech, JI Gallin
Clinical Immunology 2013
Noxa in rheumatic diseases: present understanding and future impact
KE Cottier, EM Fogle, DA Fox, S Ahmed
Rheumatology 2013
Emerging cell and cytokine targets in rheumatoid arthritis
GR Burmester, E Feist, T Dörner
Nature Reviews Rheumatology 2013
Targeting the Splicing of mRNA in Autoimmune Diseases: BAFF Inhibition in Sjögren’s Syndrome as a Proof of Concept
N Roescher, JL Vosters, G Alsaleh, P Dreyfus, S Jacques, G Chiocchia, J Sibilia, PP Tak, JA Chiorini, X Mariette, JE Gottenberg
Molecular Therapy 2013
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
F Carubbi, P Cipriani, A Marrelli, P Benedetto, P Ruscitti, O Berardicurti, I Pantano, V Liakouli, S Alvaro, A Alunno, A Manzo, F Ciccia, R Gerli, G Triolo, R Giacomelli
Arthritis Research & Therapy 2013
The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome
Y Huang, Q Cheng, C Jiang, S An, L Xiao, Y Gou, W Yu, L Lei, Q Chen, Y Wang, J Wang
Clinical & developmental immunology 2013
Possible Mechanisms of Lymphoma Development in Sjögren's Syndrome
L Dong, Y Chen, Y Masaki, T Okazaki, H Umehara
Current immunology reviews 2013
The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression
CY Sun, Y Shen, XW Chen, YC Yan, FX Wu, M Dai, T Li, CD Yang
International Journal of Rheumatology 2013
B-lymphocyte tolerance and effector function in immunity and autoimmunity
WN Khan, JA Wright, E Kleiman, JC Boucher, I Castro, ES Clark
Immunologic Research 2013
Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis: Rituximab Therapy For Primary Sjögren's Syndrome
EW St.Clair, MC Levesque, ET Prak, FB Vivino, CJ Alappatt, ME Spychala, J Wedgwood, J McNamara, KL Sivils, L Fisher, P Cohen
Arthritis & Rheumatism 2013
A (selective) history of Australian involvement in cytokine biology
NA Nicola
Cytokine & Growth Factor Reviews 2013
Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion
S Haque, XJ Yan, L Rosen, S McCormick, N Chiorazzi, PK Mongini
The FASEB Journal 2013
Murine BAFF expression is up-regulated by estrogen and interferons: Implications for sex bias in the development of autoimmunity
R Panchanathan, D Choubey
Molecular Immunology 2013
Excess CD40L does not rescue anti-DNA B cells from clonal anergy
M Aslam, Y Kishi, T Tsubata
F1000Research 2013
Excess CD40L does not rescue anti-DNA B cells from clonal anergy
M Aslam, Y Kishi, T Tsubata
F1000Research 2013
B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha
Y Kajiyama, K Kikuchi, A Takai, N Hosoya, H Hoshino, K Hino, H Miyakawa
Clinical and Developmental Immunology 2012
B cells as effectors and regulators of sex-biased arthritis
D Luckey, K Medina, V Taneja
Autoimmunity 2012
The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory
JL Karnell, R Ettinger
Frontiers in immunology 2012
B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome
W Meng, Y Li, E Xue, M Satoh, AB Peck, PL Cohen, RA Eisenberg, ET Prak
Journal of Clinical Immunology 2012
APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis
W Treamtrakanpon, P Tantivitayakul, T Benjachat, P Somparn, W Kittikowit, S Eiam-Ong, A Leelahavanichkul, N Hirankarn, Y Avihingsanon
Arthritis Research & Therapy 2012
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression
Z Brkic, NI Maria, CG van Helden-Meeuwsen, JP van de Merwe, PL van Daele, VA Dalm, ME Wildenberg, W Beumer, HA Drexhage, MA Versnel
Annals of the rheumatic diseases 2012
A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion
H Lee, S Haque, J Nieto, J Trott, JK Inman, S McCormick, N Chiorazzi, PK Mongini
Journal of immunology (Baltimore, Md. : 1950) 2012
Cellular Targeting in Autoimmunity
JL Rogers, DS Serafin, RG Timoshchenko, TK Tarrant
Current Allergy and Asthma Reports 2012
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis
X Feng, NP Reder, M Yanamandala, A Hill, BS Franek, TB Niewold, AT Reder, A Javed
Journal of the Neurological Sciences 2012
Gene cloning, expression and functional characterization of a proliferation-inducing ligand (APRIL) from hedgehog (Erinaceus europaeus)
X Cui, W Xiao, C Ji, A Tian, J Zhang, S Zhang
Molecular Biology Reports 2012
Lactoferrin Stimulates Mouse Macrophage to Express BAFF via Smad3 Pathway
HK Chang, BR Jin, YS Jang, WS Kim, PH Kim
Immune Network 2012
Signaling by the TNFR superfamily in B-cell biology and disease
RC Rickert, J Jellusova, AV Miletic
Immunological Reviews 2011
B cell depletion in autoimmune diabetes: insights from murine models
JL Chamberlain, K Attridge, CJ Wang, GA Ryan, LS Walker
Expert Opinion on Therapeutic Targets 2011
Sjögren's syndrome: studying the disease in mice
N Delaleu, CQ Nguyen, AB Peck, R Jonsson
Arthritis Research & Therapy 2011
Biomarkers in chronic graft-versus-host disease
J Rozmus, KR Schultz
Expert Review of Hematology 2011
Beyond transitional selection: New roles for BLyS in peripheral tolerance
MA Oropallo, K Kiefer, A Marshak-Rothstein, MP Cancro
Drug Development Research 2011
Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome
RA Fava, SM Kennedy, SG Wood, AI Bolstad, J Bienkowska, A Papandile, JA Kelly, CP Mavragani, M Gatumu, K Skarstein, JL Browning
Arthritis Research & Therapy 2011
Aspects of innate immunity in Sjögren's syndrome
HZ Low, T Witte
Arthritis Research & Therapy 2011
What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?
CG Kallenberg, A Vissink, FG Kroese, WH Abdulahad, H Bootsma
Arthritis Research & Therapy 2011
The Plasma Concentration of the B Cell Activating Factor Is Increased in Children With Acute Malaria
E Nduati, A Gwela, H Karanja, C Mugyenyi, J Langhorne, K Marsh, BC Urban
The Journal of Infectious Diseases 2011
Liver-expressed Igκ superantigen induces tolerance of polyclonal B cells by clonal deletion not κ to λ receptor editing
T Ota, M Ota, BH Duong, AL Gavin, D Nemazee
Journal of Experimental Medicine 2011
Loss of PKCδ results in characteristics of Sjögren’s syndrome including salivary gland dysfunction
GP Banninger, S Cha, MS Said, KM Pauley, CJ Carter, M Onate, BA Pauley, SM Anderson, ME Reyland
Oral Diseases 2011
Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome
K Yoshimoto, M Tanaka, M Kojima, Y Setoyama, H Kameda, K Suzuki, K Tsuzaka, Y Ogawa, K Tsubota, T Abe, T Takeuchi
Arthritis Research & Therapy 2011
Disturbance of cytokine networks in Sjögren's syndrome
P Youinou, JO Pers
Arthritis Research & Therapy 2011
BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
X Zhou, Z Xia, Q Lan, J Wang, W Su, YP Han, H Fan, Z Liu, W Stohl, SG Zheng
PloS one 2011
Piecing together the humoral and cellular mechanisms of immune thrombocytopenia
LJ Toltl, I Nazi, R Jafari, DM Arnold
Seminars in thrombosis and hemostasis 2011
TACI-Fc gene therapy improves auto-immune sialadenitis but not salivary gland function in NOD mice
JL Vosters, N Roescher, GG Illei, JA Chiorini, PP Tak
Oral Diseases 2011
Regulation of B cell activating factor (BAFF) receptor expression by NF-κB signaling in rheumatoid arthritis B cells
YJ Woo, BY Yoon, JY Jhun, HJ Oh, S Min, ML Cho, SH Park, HY Kim, JK Min
Experimental & molecular medicine 2011
Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies
BM Segal, AN Nazmul-Hossain, K Patel, P Hughes, KL Moser, NL Rhodus
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology 2011
Activin A Stimulates Mouse APCs to Express BAFF via ALK4-Smad3 Pathway
JH Kim, GY Seo, PH Kim
Immune Network 2011
Animal Models in Autoimmune Diseases: Lessons Learned from Mouse Models for Sjögren’s Syndrome
BH Lee, AE Gauna, KM Pauley, YJ Park, S Cha
Clinical Reviews in Allergy & Immunology 2011
Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren’s syndrome: Temporal changes in salivary glands of NOD mice
N Roescher, BM Lodde, JL Vosters, PP Tak, MA Catalan, GG Illei, JA Chiorini
Oral Diseases 2011
Autoimmunity at the ocular surface: pathogenesis and regulation
ME Stern, CS Schaumburg, R Dana, M Calonge, JY Niederkorn, SC Pflugfelder
Mucosal Immunology 2010
Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome
B Cassani, PL Poliani, V Marrella, F Schena, AV Sauer, M Ravanini, D Strina, CE Busse, S Regenass, H Wardemann, A Martini, F Facchetti, M der Burg, AG Rolink, P Vezzoni, F Grassi, E Traggiai, A Villa
Journal of Experimental Medicine 2010
Current concepts: mouse models of Sjögren's syndrome
TN Lavoie, BH Lee, CQ Nguyen
Journal of biomedicine & biotechnology 2010
Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency
JE Walter, F Rucci, L Patrizi, M Recher, S Regenass, T Paganini, M Keszei, I Pessach, PA Lang, PL Poliani, S Giliani, W Al-Herz, MJ Cowan, JM Puck, J Bleesing, T Niehues, C Schuetz, H Malech, SS DeRavin, F Facchetti, AR Gennery, E Andersson, NR Kamani, JA Sekiguchi, HM Alenezi, J Chinen, G Dbaibo, G ElGhazali, A Fontana, S Pasic, C Detre, C Terhorst, FW Alt, LD Notarangelo
Journal of Experimental Medicine 2010
B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals
SH Smith, KM Haas, JC Poe, K Yanaba, CD Ward, TS Migone, TF Tedder
International Immunology 2010
Direct B-cell Stimulation by Peripheral Blood Monocyte-derived Dendritic Cells in Idiopathic Thrombocytopenic Purpura Patients
Z Zhou, X Li, J Li, C Su, L Zhuang, S Luo, L Zhang
Journal of Clinical Immunology 2010
Current Aspects of Pathogenesis in Sjögren's Syndrome
M Voulgarelis, AG Tzioufas
Therapeutic Advances in Musculoskeletal Diseases 2010
The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation
NV Giltiay, Y Lu, D Allman, TN Jørgensen, X Li
Journal of immunology (Baltimore, Md. : 1950) 2010
Treating Sjögren's Syndrome: Insights for the Clinician
C Vitali, G Palombi, P Cataleta
Therapeutic Advances in Musculoskeletal Diseases 2010
Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease
D Zhao, JS Young, YH Chen, E Shen, T Yi, I Todorov, PG Chu, SJ Forman, D Zeng
Journal of immunology (Baltimore, Md. : 1950) 2010
BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion
M Thorn, RH Lewis, A Mumbey-Wafula, S Kantrowitz, LA Spatz
Cellular Immunology 2010
Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren’s syndrome
S Yavuz, E Asfuroğlu, M Bicakcigil, E Toker
Rheumatology International 2010
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
M Voulgarelis, AG Tzioufas
Nature Reviews Rheumatology 2010
Negative Feedback in Noncanonical NF-κB Signaling Modulates NIK Stability Through IKKα-Mediated Phosphorylation
B Razani, B Zarnegar, AJ Ytterberg, T Shiba, PW Dempsey, CF Ware, JA Loo, G Cheng
Science signaling 2010
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
S Sarantopoulos, KE Stevenson, HT Kim, CS Cutler, NS Bhuiya, M Schowalter, VT Ho, EP Alyea, J Koreth, BR Blazar, RJ Soiffer, JH Antin, J Ritz
Blood 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection
J Moorman, ZP Dong, L Ni, C Zhang, T Borthwick, ZQ Yao
Immunology 2009
Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases
C Hu, FS Wong, L Wen
Clinical & Experimental Immunology 2009
BAFF: a local and systemic target in autoimmune diseases
I Moisini, A Davidson
Clinical & Experimental Immunology 2009
B cells in autoimmunity
T Dörner, AM Jacobi, PE Lipsky
Arthritis Research & Therapy 2009
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas
RJ Bende, F Maldegem, CJ van Noesel
Haematologica 2009
Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice
CG Mayne, FE Nashold, Y Sasaki, CE Hayes
European Journal of Immunology 2009
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
DJ Wallace, W Stohl, RA Furie, JR Lisse, JD McKay, JT Merrill, MA Petri, EM Ginzler, WW Chatham, WJ McCune, V Fernandez, MR Chevrier, ZJ Zhong, WW Freimuth
Arthritis & Rheumatism 2009
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders
MC Levesque
Clinical & Experimental Immunology 2009
Cutting edge: Primary and secondary effects of CD19 deficiency on cells of the marginal zone
Y You, H Zhao, Y Wang, RH Carter
Journal of immunology (Baltimore, Md. : 1950) 2009
Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma
AJ Novak, SL Slager, ZS Fredericksen, AH Wang, MM Manske, S Ziesmer, M Liebow, WR Macon, SR Dillon, TE Witzig, JR Cerhan, SM Ansell
Cancer research 2009
Effects of acute and chronic inflammation on B-cell development and differentiation
D Cain, M Kondo, H Chen, G Kelsoe
Journal of Investigative Dermatology 2009
Autoimmunity and lymphomagenesis
LR Goldin, O Landgren
International Journal of Cancer 2009
An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
C Pena-Rossi, E Nasonov, M Stanislav, V Yakusevich, O Ershova, N Lomareva, H Saunders, J Hill, I Nestorov
Lupus 2009
CD4+CD25+ T-Cells Control Autoimmunity in the Absence of B-Cells
E Marino, J Villanueva, S Walters, D Liuwantara, F Mackay, ST Grey
Diabetes 2009
Sjögren syndrome: Advances in the pathogenesis from animal models
JA Chiorini, D Cihakova, CE Ouellette, P Caturegli
Journal of Autoimmunity 2009
Kritischer Überblick zu Outcome-Parametern bei Patienten mit primärem Sjögren-Syndrom
E Feist, A Hansen
Zeitschrift für Rheumatologie 2009
Aktuelle therapeutische Optionen bei Sjögren-Syndrom
A Hansen, T Dörner
Zeitschrift für Rheumatologie 2009
B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
SA Thompson, JL Jones, AL Cox, DA Compston, AJ Coles
Journal of Clinical Immunology 2009
BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
D Bloom, Z Chang, K Pauly, J Kwun, J Fechner, C Hayes, M Samaniego, S Knechtle
American Journal of Transplantation 2009
Expression of B-Cell Activating Factor Enhances Protective Immunity of a Vaccine against Pseudomonas aeruginosa
C Tertilt, J Joh, A Krause, P Chou, K Schneeweiss, RG Crystal, S Worgall
Infection and immunity 2009
Unraveling the Pathophysiology of Sjogren Syndrome-Associated Dry Eye Disease
Nguyen CQ, Peck AB
The ocular surface 2009
An NZW-derived interval on chromosome 7 moderates sialadenitis, but not insulitis in congenic NOD mice
Burt RA, Watkins L, Tan IK, Wang N, Quirk F, Mackin L, Morgan P, Zhang JG, Berzins SP, Morahan G, Brodnicki TC
Journal of immunology (Baltimore, Md. : 1950) 2009
Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations
N Delaleu, H Immervoll, J Cornelius, R Jonsson
Arthritis Research & Therapy 2008
Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren’s syndrome1
Y Qian, N Giltiay, J Xiao, Y Wang, J Tian, S Han, M Scott, R Carter, TN Jorgensen, X Li
European Journal of Immunology 2008
Biologic treatments for systemic rheumatic diseases
Y Shirota, GG Illei, NP Nikolov
Oral Diseases 2008
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms
A George-Chandy, E Trysberg, K Eriksson
Arthritis Research & Therapy 2008
Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta
DL Langat, DA Wheaton, JS Platt, T Sifers, JS Hunt
The American Journal of Pathology 2008
Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation
A Meyer-Bahlburg, SF Andrews, KO Yu, SA Porcelli, DJ Rawlings
Journal of Experimental Medicine 2008
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival
RT Woodland, CJ Fox, MR Schmidt, PS Hammerman, JT Opferman, SJ Korsmeyer, DM Hilbert, CB Thompson
Blood 2008
Selecting highly sensitive non-obese diabetic mice for improving the study of Sjögren’s syndrome
W Xiao, Y Wu, J Zhang, W Ye, GT Xu
Graefe's Archive for Clinical and Experimental Ophthalmology 2008
Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium
SD Sanjose, Y Benavente, CM Vajdic, EA Engels, LM Morton, PM Bracci, JJ Spinelli, T Zheng, Y Zhang, S Franceschi, R Talamini, EA Holly, AE Grulich, JR Cerhan, P Hartge, W Cozen, P Boffetta, P Brennan, M Maynadié, P Cocco, R Bosch, L Foretova, A Staines, N Becker, A Nieters
Clinical Gastroenterology and Hepatology 2008
BLyS Regulates Adaptive Immune Responses by Directly Promoting Dendritic Cell Maturation
Chang SK, Mihalcik SA, Jelinek DF
Journal of immunology (Baltimore, Md. : 1950) 2008
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
Rasheed Z, Haqqi TM
Current rheumatology reviews 2008
Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion
Li X, Su K, Ji C, Szalai AJ, Wu J, Zhang Y, Zhou T, Kimberly RP, Edberg JC
Journal of immunology (Baltimore, Md. : 1950) 2008
Augmented interferon-α pathway activation in patients with Sjögren's syndrome treated with etanercept
CP Mavragani, TB Niewold, NM Moutsopoulos, SR Pillemer, SM Wahl, MK Crow
Arthritis & Rheumatism 2007
B cells in glomerulonephritis: focus on lupus nephritis
MR Clatworthy, KG Smith
Seminars in Immunopathology 2007
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
SR Christensen, MJ Shlomchik
Seminars in Immunology 2007
B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue
A Hansen, PE Lipsky, T Dörner
Arthritis Research & Therapy 2007
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
JR Groom, CA Fletcher, SN Walters, ST Grey, SV Watt, MJ Sweet, MJ Smyth, CR Mackay, F Mackay
Journal of Experimental Medicine 2007
Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator
A Hever, RB Roth, P Hevezi, ME Marin, JA Acosta, H Acosta, J Rojas, R Herrera, D Grigoriadis, E White, PJ Conlon, RA Maki, A Zlotnik
Proceedings of the National Academy of Sciences 2007
Developments in lupus 2006
A Hansen, F Hiepe, T Dörner
Arthritis Research & Therapy 2007
Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint
LK Assi, SH Wong, A Ludwig, K Raza, C Gordon, M Salmon, JM Lord, D Scheel-Toellner
Arthritis & Rheumatism 2007
Notes on the kidney and its diseases for the neurologist
MS Zandi, AJ Coles
Journal of neurology, neurosurgery, and psychiatry 2007
Sequence Analysis of TNFRSF13b, Encoding TACI, in Patients with Systemic Lupus Erythematosus
U Salzer, J Birmelin, C Bacchelli, T Witte, U Buchegger-Podbielski, S Buckridge, R Rzepka, HB Gaspar, AJ Thrasher, RE Schmidt, I Melchers, B Grimbacher
Journal of Clinical Immunology 2007
Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients
Z Lin, Y Dan-Rong, T Xiao-Qing, W Hao, G Hong-Lian, K Xian-Tao, Z Ren-Qian, L Jiyu
Journal of Clinical Laboratory Analysis 2007
Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers
A Munafo, A Priestley, I Nestorov, J Visich, M Rogge
European Journal of Clinical Pharmacology 2007
Indikation und Option neuer immunmodulatorischer Therapien beim Sjögren-Syndrom
E Feist, T Dörner, A Hansen
Zeitschrift für Rheumatologie 2007
Animal Models of Sjögren’s Syndrome
MV Jonsson, N Delaleu, R Jonsson
Clinical Reviews in Allergy & Immunology 2007
The Role of Epithelial Cells in the Pathogenesis of Sjögren’s Syndrome
MN Manoussakis, EK Kapsogeorgou
Clinical Reviews in Allergy & Immunology 2007
T Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of Pathophysiology
GE Katsifis, NM Moutsopoulos, SM Wahl
Clinical Reviews in Allergy & Immunology 2007
Clinical, Immunologic, and Molecular Factors Predicting Lymphoma Development in Sjogren’s Syndrome Patients
M Voulgarelis, FN Skopouli
Clinical Reviews in Allergy & Immunology 2007
A conspicuous role for B cells In Sjögren's syndrome
P Youinou, V Devauchelle, P Hutin, RL Berre, A Saraux, JO Pers
Clinical Reviews in Allergy & Immunology 2007
Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome: Sjögren's syndrome and lymphoproliferative disorder
L Dong, Y Masaki, T Takegami, ZX Jin, CR Huang, T Fukushima, T Sawaki, T Kawanami, T Saeki, K Kitagawa, S Sugai, T Okazaki, Y Hirose, H Umehara
Clinical & Experimental Immunology 2007
High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency
AK Knight, L Radigan, T Marron, A Langs, L Zhang, C Cunningham-Rundles
Clinical Immunology 2007
Similarities and differences between selective and non-selective BAFF blockade in murine SLE
Meera Ramanujam, Xiaobo Wang, Weiqing Huang, Zheng Liu, Lena Schiffer, Haiou Tao, Daniel Frank, Jeffrey Rice, Betty Diamond, Karl O.A. Yu, Steven Porcelli, and Anne Davidson.
Journal of Clinical Investigation 2006
Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity
T So, SW Lee, M Croft
International Journal of Hematology 2006
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus
J Sellam, C Miceli-Richard, JE Gottenberg, M Ittah, F Lavie, C Lacabaratz, N Gestermann, A Proust, O Lambotte, X Mariette
Annals of the rheumatic diseases 2006
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
T Vallerskog, M Heimbürger, I Gunnarsson, W Zhou, M Wahren-Herlenius, C Trollmo, V Malmström
Arthritis Research & Therapy 2006
Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase
JS Oak, JA Deane, MG Kharas, J Luo, TE Lane, LC Cantley, DA Fruman
Proceedings of the National Academy of Sciences 2006
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
F Lavie, C Miceli-Richard, M Ittah, J Sellam, JE Gottenberg, X Mariette
Annals of the rheumatic diseases 2006
A role for BLyS in the activation of innate immune cells
SK Chang, BK Arendt, JR Darce, X Wu, DF Jelinek
Blood 2006
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome
M Ittah, C Miceli-Richard, JE Gottenberg, F Lavie, T Lazure, N Ba, J Sellam, C Lepajolec, X Mariette
Arthritis Research & Therapy 2006
No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
JE Gottenberg, J Sellam, M Ittah, F Lavie, A Proust, H Zouali, C Sordet, J Sibilia, RP Kimberly, X Mariette, C Miceli-Richard
Arthritis Research & Therapy 2006
A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys
Y Vugmeyster, D Seshasayee, W Chang, A Storn, K Howell, S Sa, T Nelson, F Martin, I Grewal, E Gilkerson, B Wu, J Thompson, BN Ehrenfels, S Ren, A Song, TR Gelzleichter, DM Danilenko
The American Journal of Pathology 2006
Sjögren-Syndrom: Aktuelle Aspekte aus rheumatologischer Sicht
C Tomiak, T Dörner
Zeitschrift für Rheumatologie 2006
Selective activation of TACI by syndecan-2
D Bischof, SF Elsawa, G Mantchev, J Yoon, GE Michels, A Nilson, SL Sutor, JL Platt, SM Ansell, G von Bulow, RJ Bram
Blood 2006
Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
Ju ZL, Shi GY, Zuo JX, Zhang JW
Immunology 2006
Lymphoma and other malignancies in primary Sjögren's syndrome.
Pillemer SR
Annals of the rheumatic diseases 2006
BLyS and APRIL in Rheumatoid Arthritis
Thorsten M. Seyler, Yong W. Park, Seisuke Takemura, Richard J. Bram, Paul J. Kurtin, Jörg J. Goronzy, Cornelia M. Weyand
Journal of Clinical Investigation 2005
Impaired early B cell tolerance in patients with rheumatoid arthritis
J Samuels, YS Ng, C Coupillaud, D Paget, E Meffre
Journal of Experimental Medicine 2005
A fundamental bimodal role for neuropeptide Y1 receptor in the immune system
J Wheway, CR Mackay, RA Newton, A Sainsbury, D Boey, H Herzog, F Mackay
Journal of Experimental Medicine 2005
Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
M Voulgarelis, S Giannouli, AG Tzioufas, HM Moutsopoulos
Annals of the rheumatic diseases 2005
Identification and characterization of circulating human transitional B cells
GP Sims, R Ettinger, Y Shirota, CH Yarboro, GG Illei, PE Lipsky
Blood 2005
Association Between Circulating Levels of the Novel TNF Family Members APRIL and BAFF and Lymphoid Organization in Primary Sjögren’s Syndrome
MV Jonsson, P Szodoray, S Jellestad, R Jonsson, K Skarstein
Journal of Clinical Immunology 2005
Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
T Ring, M Kallenbach, J Prætorius, S Nielsen, B Melgaard
Clinical Rheumatology 2005
Inhibitory oligodeoxynucleotides – therapeutic promise for systemic autoimmune diseases?
P Lenert
Clinical & Experimental Immunology 2005
Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo
D Panagopoulos, P Victoratos, M Alexiou, G Kollias, G Mosialos
Journal of virology 2004
Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome
GJ Shim, M Warner, HJ Kim, S Andersson, L Liu, J Ekman, O Imamov, ME Jones, ER Simpson, JA Gustafsson
Proceedings of the National Academy of Sciences 2004
Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis
M Schaller, W Stohl, SM Tan, VM Benoit, DM Hilbert, HJ Ditzel
Annals of the rheumatic diseases 2004
The current status of targeting BAFF/BLyS for autoimmune diseases
M Ramanujam, A Davidson
Arthritis Research & Therapy 2004
Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity
SA Johnson, JC Cambier
Arthritis Research & Therapy 2004
APRIL-deficient mice have normal immune system development
E Varfolomeev, F Kischkel, F Martin, D Seshasayee, H Wang, D Lawrence, C Olsson, L Tom, S Erickson, D French, P Schow, IS Grewal, A Ashkenazi
Molecular and cellular biology 2004
Programmed Cell Death of Peripheral Blood B Cells Determined by Laser Scanning Cytometry in Sj�gren?s Syndrome with a Special Emphasis on BAFF
P Szodoray, S Jellestad, P Alex, T Zhou, PC Wilson, M Centola, JG Brun, R Jonsson
Journal of Clinical Immunology 2004
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
Danielle T. Avery, Susan L. Kalled, Julia I. Ellyard, Christine Ambrose, Sarah A. Bixler, Marilyn Thien, Robert Brink, Fabienne Mackay, Philip D. Hodgkin, Stuart G. Tangye
Journal of Clinical Investigation 2003
Targeting B cells for the treatment of rheumatoid arthritis
TJ Oligino, SA Dalrymple
Arthritis Research & Therapy 2003
Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome
MR Kok, BJ Baum, PP Tak, SR Pillemer
Annals of the rheumatic diseases 2003
SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder
W Stohl
Arthritis Research & Therapy 2003
B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells
TG Phan, M Amesbury, S Gardam, J Crosbie, J Hasbold, PD Hodgkin, A Basten, R Brink
Journal of Experimental Medicine 2003
G-CSF-stimulated neutrophils are a prominent source of functional BLyS
P Scapini, B Nardelli, G Nadali, F Calzetti, G Pizzolo, C Montecucco, MA Cassatella
Journal of Experimental Medicine 2003
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome
X Mariette, S Roux, J Zhang, D Bengoufa, F Lavie, T Zhou, R Kimberly
Annals of the rheumatic diseases 2003
Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome
R Jonsson, TP Gordon, YT Konttinen
Current Rheumatology Reports 2003
Manipulation of Lymphoid Microenvironments in Non-Human Primates by an Inhibitor of the Lymphotoxin Pathway
Jennifer L. Gommerman, Fabienne Mackay, Elina Donskoy, Werner Meier, Pauline Martin, Jeffrey L. Browning
Journal of Clinical Investigation 2002
The buzz about BAFF
David Vaux
Journal of Clinical Investigation 2002
Sjögren's syndrome criteria
R Manthorpe
Annals of the rheumatic diseases 2002
Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.
Dörner T, Lipsky PE
Arthritis research 2002

← Previous 1 2 3 … 11 12 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 47 patents
Referenced in 2 Wikipedia pages
72 readers on Mendeley
See more details